Authors:
Ross, L
Henry, K
Paar, D
Salvato, P
Shaefer, M
Fisher, R
Liao, QM
St Clair, M
Citation: L. Ross et al., Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens, J HUMAN VIR, 4(4), 2001, pp. 217-222
Authors:
Ross, L
Scarsella, A
Raffanti, S
Henry, K
Becker, S
Fisher, R
Liao, QM
Hirani, A
Graham, N
St Clair, M
Hernandez, J
Citation: L. Ross et al., Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens, AIDS RES H, 17(12), 2001, pp. 1107-1115
Authors:
Ross, L
Vavro, CL
Kehne, SL
McClernon, DR
St Clair, M
Citation: L. Ross et al., Substitution of a commercially available, RNA extraction procedure in an HIV-1 genotyping system improves sensitivity and allows reduced sample volume, J VIROL MET, 96(1), 2001, pp. 1-4
Authors:
Chan, JH
Hong, JS
Hunter, RN
Orr, GF
Cowan, JR
Sherman, DB
Sparks, SM
Reitter, BE
Andrews, CW
Hazen, RJ
St Clair, M
Boone, LR
Ferris, RG
Creech, KL
Roberts, GB
Short, SA
Weaver, K
Ott, RJ
Ren, JS
Hopkins, A
Stuart, DI
Stammers, DK
Citation: Jh. Chan et al., 2-amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1, J MED CHEM, 44(12), 2001, pp. 1866-1882
Authors:
Ross, L
Johnson, M
Ferris, RG
Short, SA
Boone, LR
Melby, TE
Lanier, R
Shaefer, M
St Clair, M
Citation: L. Ross et al., Deletions in the beta 3-beta 4 hairpin loop of HIV-1 reverse transcriptaseare observed in HIV-1 isolated from subjects during long-term antiretroviral therapy, J HUMAN VIR, 3(3), 2000, pp. 144-149
Authors:
Ross, L
Johnson, M
DeMasi, R
Liao, QM
Graham, N
Shaefer, M
St Clair, M
Citation: L. Ross et al., Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia, AIDS, 14(7), 2000, pp. 813-819
Authors:
Kuritzkes, DR
Sevin, A
Young, B
Bakhtiari, M
Wu, HL
St Clair, M
Connick, E
Landay, A
Spritzler, J
Kessler, H
Lederman, MM
Citation: Dr. Kuritzkes et al., Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group protocol 315, J INFEC DIS, 181(2), 2000, pp. 491-497
Authors:
Connick, E
Lederman, MM
Kotzin, BL
Spritzler, J
Kuritzkes, DR
St Clair, M
Sevin, AD
Fox, L
Chiozzi, MH
Leonard, JM
Rousseau, F
Roe, JD
Martinez, A
Kessler, H
Landay, A
Citation: E. Connick et al., Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response, J INFEC DIS, 181(1), 2000, pp. 358-363
Authors:
Chien, JW
Valdez, H
McComsey, G
McClernon, D
St Clair, M
Lederman, MM
Citation: Jw. Chien et al., Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients, J ACQ IMM D, 21(4), 1999, pp. 277-280
Authors:
Ross, L
Johnson, M
Graham, N
Shaefer, M
St Clair, M
Citation: L. Ross et al., The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy, J HUMAN VIR, 2(5), 1999, pp. 290-295
Authors:
Spear, GT
Olinger, G
Sullivan, BL
Landay, AL
Kessler, H
Connick, E
Kuritzkes, D
St Clair, M
Spritzler, J
Wu, H
Lederman, MM
Citation: Gt. Spear et al., Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons, AIDS RES H, 15(18), 1999, pp. 1713-1715
Authors:
Ross, L
Vavro, C
Zimmermann, A
St Clair, M
Citation: L. Ross et al., Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes, AIDS RES H, 15(14), 1999, pp. 1287-1292